Idiopathic generalized epilepsy

disorder

SNOMED 36803009CUI C0270850

Overview

Idiopathic generalized epilepsy is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Clinical Trials

Total Trials

Recruiting

With Results

Recent Trials

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

NCT00267202Phase 4Completed275 enrolled

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

NCT03940326Phase 4Completed103 enrolled

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

NCT00670930Phase 4Completed36 enrolled

View all 3 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

EEG with spike-wave complexes (>3.5 Hz)

HP:0010849

Generalized myoclonic seizure

HP:0002123

Generalized non-motor (absence) seizure

HP:0002121

Generalized tonic-clonic seizure (without specification of onset)

HP:0002069

Related Conditions

Juvenile absence epilepsy(child)

Epilepsy with generalised tonic-clonic seizures alone(child)

Childhood absence epilepsy(child)

Juvenile myoclonic epilepsy(child)

Genetic generalised epilepsy(parent)

Quick Facts

SNOMED CT: 36803009
UMLS CUI: C0270850
Fully Specified Name: Idiopathic generalized epilepsy (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 4
Clinical Trials: 3

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.